Company news
Vera Therapeutics, Inc. news in 2021
Vera Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Vera Therapeutics Announces Acquisition of Monoclonal Antibody From Pfizer to Treat BK Virus in Transplant Patients
December 16, 2021
Vera Therapeutics Announces Appointment of Kimball Hall to Board of Directors
December 13, 2021
Vera Therapeutics to Present at Upcoming Investment Conferences in November 2021
November 9, 2021
Vera Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 9, 2021
Vera Therapeutics Presents Phase 2a Data Showing Atacicept Reduces Serum Gd-IgA1 in Patients with IgA Nephropathy at the American Society of Nephrology Kidney Week 2021
November 3, 2021
Vera Therapeutics to Present Phase 2a Data on Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week 2021 Annual Meeting
October 12, 2021
Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephropathy
September 8, 2021
Vera Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 15, 2021
Vera Therapeutics Appoints Sean Grant as Chief Financial Officer
July 13, 2021
Vera Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
June 23, 2021
Vera Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
May 26, 2021
Vera Therapeutics Announces Pricing of Initial Public Offering
May 12, 2021